Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

Millipede, Inc. is developing the IRIS Transcatheter Annuloplasty Ring System to treat severe mitral regurgitation MARLBOROUGH, Mass., Jan. 24, 2018 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (NYSE: BSX) today announced ... Devices, Interventional, Cardiology, Mergers & Acquisitions Boston Scientific, Millipede, Transcatheter, Annuloplasty Ring
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news